Erasca Balance Sheet Health
Financial Health criteria checks 6/6
Erasca has a total shareholder equity of $316.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $395.3M and $78.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$312.35m |
Equity | US$316.69m |
Total liabilities | US$78.61m |
Total assets | US$395.30m |
Recent financial health updates
Is Erasca (NASDAQ:ERAS) In A Good Position To Deliver On Growth Plans?
Feb 21We Think Erasca (NASDAQ:ERAS) Needs To Drive Business Growth Carefully
Nov 16Companies Like Erasca (NASDAQ:ERAS) Are In A Position To Invest In Growth
Jun 28We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth
Jan 20Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation
Sep 23We're Not Very Worried About Erasca's (NASDAQ:ERAS) Cash Burn Rate
Apr 12Recent updates
Is Erasca (NASDAQ:ERAS) In A Good Position To Deliver On Growth Plans?
Feb 21We Think Erasca (NASDAQ:ERAS) Needs To Drive Business Growth Carefully
Nov 16Companies Like Erasca (NASDAQ:ERAS) Are In A Position To Invest In Growth
Jun 28We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth
Jan 20Erasca forms clinical trial partnership with Pfizer for cancer therapy
Oct 20Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation
Sep 23Erasca adds 10% ahead of R&D Day
Sep 07Erasca, Eli Lilly to collaborate on trial to evaluate combo treatment for two cancers
Jul 18We're Not Very Worried About Erasca's (NASDAQ:ERAS) Cash Burn Rate
Apr 12Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation
Dec 28Financial Position Analysis
Short Term Liabilities: ERAS's short term assets ($320.7M) exceed its short term liabilities ($26.2M).
Long Term Liabilities: ERAS's short term assets ($320.7M) exceed its long term liabilities ($52.5M).
Debt to Equity History and Analysis
Debt Level: ERAS is debt free.
Reducing Debt: ERAS has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ERAS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ERAS has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 25.1% each year.